SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001019687-14-003402
Filing Date
2014-08-28
Accepted
2014-08-28 16:57:45
Documents
8
Period of Report
2014-10-16
Effectiveness Date
2014-08-28

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT peregrine_def14a.htm DEF 14A 515776
2 GRAPHIC peregrine_logo.jpg GRAPHIC 15068
3 GRAPHIC image_001.jpg GRAPHIC 11455
4 GRAPHIC graph.jpg GRAPHIC 25854
5 GRAPHIC proxy1.jpg GRAPHIC 58152
6 GRAPHIC proxy2.jpg GRAPHIC 58536
7 GRAPHIC proxy3.jpg GRAPHIC 48371
8 GRAPHIC proxy4.jpg GRAPHIC 91811
  Complete submission text file 0001019687-14-003402.txt   944024
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-32839 | Film No.: 141072469
SIC: 2834 Pharmaceutical Preparations